| Summary: | We report a genomic and phenotypic delineation for two chromosome regions with candidate genes for syndromic intellectual disability at 12q12 and Xp22.31, segregating independently in one family with four affected members. Fine mapping of three affected members, along with six unreported small informative CNVs, narrowed down the candidate chromosomal interval to one gene <i>LRRK2</i> at 12q12. Expression studies revealed high levels of <i>LRRK2</i> transcripts in the whole human brain, cerebral cortex and hippocampus. RT-qPCR assays revealed that <i>LRRK2</i> transcripts were dramatically reduced in our microdeletion patient DGDP289A compared to his healthy grandfather with no deletion. The decreased expression of LRRK2 may affect protein−protein interactions between LRRK2 and its binding partners, of which eight have previously been linked to intellectual disability. These findings corroborate with a role for LRRK2 in cognitive development, and, thus, we propose that intellectual disability and autism, displayed in the 12q12 microdeletions, are likely caused by <i>LRRK2</i>. Using another affected member, DGDP289B, with a microdeletion at Xp22.31, in this family, we performed the genomic and clinical delineation with six published and nine unreported cases. We propose <i>HDHD1</i> and <i>PNPLA4</i> for X-linked intellectual disability in this region, since their high transcript levels in the human brain substantiate their role in intellectual functioning.
|
|---|
